Tumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9.

Trial Profile

Tumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 03 Mar 2017

At a glance

  • Drugs Burtomab I 131 (Primary)
  • Indications Brain cancer; Ewing's sarcoma; Neuroblastoma; Osteosarcoma; Primitive neuroectodermal tumours; Rhabdomyosarcoma; Solid tumours
  • Focus Diagnostic use
  • Most Recent Events

    • 10 Jan 2017 Status changed from completed to discontinued.
    • 21 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top